| M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia (NCT05739630) | The First Affiliated Hospital of Soochow University | 2023-01-01 |
| A Study of Oxytocin PK After IV Administration in Healthy Subjects and Advanced Knee Arthritis Subjects (NCT04429880) | Wake Forest University Health Sciences | 2023-01-01 |
| Eat My ABCs Project (NCT05780008) | Michigan State University | 2023-01-01 |
| Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma (NCT06653517) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2023-01-01 |
| Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies (NCT05672420) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-01-01 |
| Tislelizumab With Anlotinib and Chemotherapy for Second-line Treatment of Pancreatic Cancer (NCT05681390) | First Affiliated Hospital Xi'an Jiaotong University | 2023-01-01 |
| HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis (NCT05648487) | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 2023-01-01 |
| A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma (NCT05590572) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-01-01 |
| An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities (NCT05532020) | Soleno Therapeutics, Inc. | 2023-01-01 |
| Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults (NCT04386252) | Aivita Biomedical, Inc. | 2023-01-01 |
| Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients (NCT06169072) | Vastra Gotaland Region | 2023-01-01 |
| Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy. (NCT05727098) | National Cancer Institute, Egypt | 2023-01-01 |
| Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism (NCT05472493) | University of Calgary | 2023-01-01 |
| Effect of SSRIs on Response to Psilocybin Therapy (NCT05594667) | Cybin Therapeutics Inc. | 2023-01-01 |
| Efficacy of ASIMOMMY® Compared to Domperidone and Placebo in Increasing Breastfeeding: Randomized Single-Blind Controlled Trial in Indonesia (NCT05596006) | Gadjah Mada University | 2022-12-31 |
| Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor (NCT05536128) | Seoul National University Hospital | 2022-12-31 |
| Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone (NCT04325802) | University of Minnesota | 2022-12-31 |
| IPS Differentiated Cardiomyocytes Vein Transplantation for Chronic Heart Failure (NCT03759405) | Beijing University of Chinese Medicine | 2022-12-31 |
| Study of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors (NCT05765032) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-12-30 |
| Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention (NCT06017479) | Indonesia University | 2022-12-30 |
| Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis (NCT05121402) | TLL Pharmaceutical, LLC | 2022-12-30 |
| PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced Melanoma (NCT05466474) | Henan Cancer Hospital | 2022-12-30 |
| PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer (NCT05659186) | West China Hospital | 2022-12-30 |
| A Study of Tucatinib and Trastuzumab in People With Rectal Cancer (NCT05672524) | Memorial Sloan Kettering Cancer Center | 2022-12-30 |
| The Purpose of This Study is to Evaluate the Safety and Efficacy of Human TH-SC01 Cell Injection in the Treatment of Complex Perianal Fistula (NCT05677672) | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | 2022-12-30 |
| A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine (NCT05519839) | Novavax | 2022-12-30 |
| Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers (NCT03137966) | Karolinska University Hospital | 2022-12-30 |
| SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease (NCT05628233) | Sensorion | 2022-12-30 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19 (NCT05689203) | Qilu Pharmaceutical Co., Ltd. | 2022-12-30 |
| Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC) (NCT05837806) | Tianjin Medical University Second Hospital | 2022-12-30 |
| Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate) (NCT05457699) | Centre hospitalier de l'Université de Montréal (CHUM) | 2022-12-30 |
| SNF Platform Study of HR+/ HER2-advanced Breast Cancer (NCT05594095) | Fudan University | 2022-12-30 |
| A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential Hypertension (NCT07700875) | Wuhan Createrna Science and Technology Co., Ltd | 2022-12-29 |
| Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus (NCT05591222) | Amgen | 2022-12-29 |
| A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. (NCT05627362) | Ipsen | 2022-12-29 |
| Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT05673057) | Molecular Partners AG | 2022-12-29 |
| Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 (NCT05633433) | Shanghai Henlius Biotech | 2022-12-29 |
| Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer (NCT05687851) | Chongqing University Cancer Hospital | 2022-12-29 |
| CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies (NCT05442515) | National Cancer Institute (NCI) | 2022-12-28 |
| Study of SDX in Patients With Idiopathic Hypersomnia (IH) (NCT05668754) | Zevra Therapeutics | 2022-12-28 |
| Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma (NCT05526989) | H. Lee Moffitt Cancer Center and Research Institute | 2022-12-28 |
| Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases (NCT05692037) | Zhongda Hospital | 2022-12-28 |
| Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression (NCT04920708) | Royal Marsden NHS Foundation Trust | 2022-12-28 |
| Prevention of Postpartum Hemorrhage With Tranexamic Acid (NCT05370820) | Inova Health Care Services | 2022-12-28 |
| Biological Response to Platelet-rich Plasma and Corticosteroid Injections (NCT05657496) | University of Missouri-Columbia | 2022-12-28 |
| A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC) (NCT05613413) | University of Illinois at Chicago | 2022-12-28 |
| Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (NCT05396105) | Pharvaris Netherlands B.V. | 2022-12-28 |
| A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (NCT05648214) | Regeneron Pharmaceuticals | 2022-12-27 |
| Study of EQU-001 for Uncontrolled Focal Onset Seizures (NCT05473442) | Equilibre Biopharmaceuticals B.V. | 2022-12-27 |
| HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes (NCT05623189) | HighTide Therapeutics (Hong Kong) Limited | 2022-12-27 |
| Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab (NCT06003998) | Catharina Ziekenhuis Eindhoven | 2022-12-27 |
| Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors (NCT05745623) | Beijing InnoCare Pharma Tech Co., Ltd. | 2022-12-27 |
| Ketamine Effects as Preemptive Analgesia (NCT06040060) | Universitas Padjadjaran | 2022-12-27 |
| Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells (NCT03673748) | Red de Terapia Celular | 2022-12-27 |
| A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis (NCT05593666) | Drugs for Neglected Diseases | 2022-12-27 |
| The Study of CM326 in Moderate-to-severe Atopic Dermatitis (NCT05671432) | Keymed Biosciences Co.Ltd | 2022-12-27 |
| A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease (NCT05709444) | Palatin Technologies, Inc | 2022-12-26 |
| The Effect of Amantadine on Post-COVD-19 Fatigue (NCT05667077) | Shahid Beheshti University of Medical Sciences | 2022-12-26 |
| Intraoral Injection of Trigger Points by Botox (NCT05673655) | Fayoum University | 2022-12-25 |
| Trivalent Chromium Treatment for Rheumatoid Arthritis (NCT05545020) | Alexandria University | 2022-12-25 |
| Clinical Study of Venetoclax Combined with CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (NCT05659992) | Chinese PLA General Hospital | 2022-12-25 |
| Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy (NCT05584267) | Hunan Province Tumor Hospital | 2022-12-25 |
| Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT） (NCT05650216) | Shanghai Chest Hospital | 2022-12-25 |
| Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II Trial (NCT05942573) | Tianjin Medical University Cancer Institute and Hospital | 2022-12-24 |
| Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA) (NCT05615922) | NYU Langone Health | 2022-12-24 |
| ALG.APV-527 First-in-human Study (NCT05934539) | Aptevo Therapeutics | 2022-12-23 |
| NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma (NCT05664217) | Nektar Therapeutics | 2022-12-23 |
| Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma (NCT05512351) | Henan Provincial People's Hospital | 2022-12-23 |
| Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity) (NCT05770570) | Memorial Sloan Kettering Cancer Center | 2022-12-22 |
| Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia (NCT05665387) | Santen Inc. | 2022-12-22 |
| A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant (NCT05675930) | Memorial Sloan Kettering Cancer Center | 2022-12-22 |
| ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer (NCT05446298) | OncoC4, Inc. | 2022-12-22 |
| A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (NCT05176951) | Insmed Incorporated | 2022-12-22 |
| Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer (NCT05757336) | Lu Wang, MD, PhD | 2022-12-22 |
| Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT (NCT05682755) | Sichuan University | 2022-12-22 |
| Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers (NCT05131919) | The Netherlands Cancer Institute | 2022-12-22 |
| A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer (NCT05619172) | SOTIO Biotech AG | 2022-12-22 |
| A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype (NCT05522439) | Jiangsu HengRui Medicine Co., Ltd. | 2022-12-22 |
| Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET (NCT05420636) | Fox Chase Cancer Center | 2022-12-21 |
| PEA vs. Placebo for Major Depression (NCT06063369) | The Israeli Medical Center for Alzheimer's | 2022-12-21 |
| A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination (NCT05525247) | Selecxine | 2022-12-21 |
| The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME) (NCT05573100) | Curacle Co., Ltd. | 2022-12-21 |
| Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab (NCT05694884) | ASLAN Pharmaceuticals | 2022-12-21 |
| Periocular Rejuvenation by Topical Hyaluronic Acid Nano Particles (NCT05742399) | Alexandria University | 2022-12-21 |
| A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome (NCT05643794) | UCB Biopharma SRL | 2022-12-21 |
| A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis (NCT05656911) | Bayer | 2022-12-21 |
| Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses (NCT05674825) | Medical College of Wisconsin | 2022-12-21 |
| Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer (NCT05475678) | Zhenzhen Liu | 2022-12-20 |
| Asparagus Capsule Consumption and Blood Sugar and Lipids and Oxidative Stress (NCT06195813) | Burapha University | 2022-12-20 |
| A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED) (NCT05487599) | Prevail Therapeutics | 2022-12-20 |
| The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (NCT06211062) | Nova Southeastern University | 2022-12-20 |
| Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies. (NCT05190094) | International Cancer Research Group, United Arab Emirates | 2022-12-20 |
| Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma (NCT05535166) | St. Jude Children's Research Hospital | 2022-12-20 |
| Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation (NCT04935684) | University Hospital, Clermont-Ferrand | 2022-12-20 |
| Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN) (NCT05660538) | Vertex Pharmaceuticals Incorporated | 2022-12-20 |
| TIME in Immunotherapy Combined With nCRT for Rectal Cancer (NCT05507112) | Peking Union Medical College Hospital | 2022-12-20 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia (NCT05677438) | Chong Kun Dang Pharmaceutical | 2022-12-20 |
| Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer (NCT05638594) | Shengjing Hospital | 2022-12-20 |
| Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas (NCT05751798) | OSE Immunotherapeutics | 2022-12-20 |
| Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy (NCT05637086) | Mostafa Bahaa | 2022-12-20 |